United American Healthcare Corporation (UAHC)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 119 Thousand USD | 133.33% |
| 2022 | 51 Thousand USD | -63.31% |
| 2021 | 139 Thousand USD | -97.93% |
| 2020 | 6.72 Million USD | -86.66% |
| 2019 | 50.42 Million USD | 0.0% |
| 2013 | 12.77 Million USD | -2.35% |
| 2012 | 13.08 Million USD | 3.91% |
| 2011 | 12.59 Million USD | 19.02% |
| 2010 | 10.58 Million USD | 49.39% |
| 2009 | 7.08 Million USD | 9.68% |
| 2008 | 6.45 Million USD | 5.4% |
| 2007 | 6.12 Million USD | 92.92% |
| 2006 | 3.17 Million USD | -15.35% |
| 2005 | 3.75 Million USD | -27.79% |
| 2004 | 5.19 Million USD | -34.84% |
| 2003 | 7.97 Million USD | -74.76% |
| 2002 | 31.58 Million USD | 7.65% |
| 2001 | 29.34 Million USD | 23.51% |
| 2000 | 23.75 Million USD | -38.93% |
| 1999 | 38.9 Million USD | -21.57% |
| 1998 | 49.6 Million USD | 9.49% |
| 1997 | 45.3 Million USD | -18.08% |
| 1996 | 55.3 Million USD | 219.65% |
| 1995 | 17.3 Million USD | 51.75% |
| 1994 | 11.4 Million USD | 90.0% |
| 1993 | 6 Million USD | 76.47% |
| 1992 | 3.4 Million USD | -17.07% |
| 1991 | 4.1 Million USD | 5.13% |
| 1990 | 3.9 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 46 Thousand USD | 0.0% |
| 2023 Q3 | - USD | -100.0% |
| 2023 Q2 | 88 Thousand USD | 4.76% |
| 2023 Q1 | 84 Thousand USD | 0.0% |
| 2023 FY | 119 Thousand USD | 133.33% |
| 2022 FY | 51 Thousand USD | -63.31% |
| 2022 Q2 | 87 Thousand USD | 27.94% |
| 2022 Q1 | 68 Thousand USD | 0.0% |
| 2021 Q1 | 6.21 Million USD | 0.0% |
| 2021 FY | 139 Thousand USD | -97.93% |
| 2021 Q2 | 3.82 Million USD | -38.44% |
| 2020 FY | 6.72 Million USD | -86.66% |
| 2019 FY | 50.42 Million USD | 0.0% |
| 2018 Q3 | 14.86 Million USD | -13.26% |
| 2018 Q1 | 19.66 Million USD | 0.0% |
| 2018 Q2 | 17.14 Million USD | -12.83% |
| 2018 Q4 | 16.07 Million USD | 8.09% |
| 2017 Q3 | 20.75 Million USD | 0.0% |
| 2014 Q1 | 13.11 Million USD | 0.0% |
| 2014 Q2 | 13.1 Million USD | -0.08% |
| 2014 Q3 | 13.03 Million USD | -0.55% |
| 2013 Q3 | 12.68 Million USD | -0.75% |
| 2013 FY | 12.77 Million USD | -2.35% |
| 2013 Q1 | 12.67 Million USD | 0.64% |
| 2013 Q2 | 12.77 Million USD | 0.84% |
| 2012 Q1 | 13.66 Million USD | 6.39% |
| 2012 FY | 13.08 Million USD | 3.91% |
| 2012 Q2 | 13.08 Million USD | -4.21% |
| 2012 Q3 | 12.92 Million USD | -1.23% |
| 2012 Q4 | 12.58 Million USD | -2.59% |
| 2011 Q4 | 12.83 Million USD | -1.62% |
| 2011 Q1 | 7.27 Million USD | -19.22% |
| 2011 FY | 12.59 Million USD | 19.02% |
| 2011 Q2 | 12.59 Million USD | 73.03% |
| 2011 Q3 | 13.05 Million USD | 3.63% |
| 2010 Q1 | 1.41 Million USD | -52.07% |
| 2010 FY | 10.58 Million USD | 49.39% |
| 2010 Q4 | 9.01 Million USD | -9.32% |
| 2010 Q3 | 9.93 Million USD | -6.1% |
| 2010 Q2 | 10.58 Million USD | 649.36% |
| 2009 Q1 | 4.35 Million USD | -11.38% |
| 2009 Q4 | 2.94 Million USD | -23.74% |
| 2009 FY | 7.08 Million USD | 9.68% |
| 2009 Q3 | 3.86 Million USD | -45.46% |
| 2009 Q2 | 7.08 Million USD | 62.68% |
| 2008 FY | 6.45 Million USD | 5.4% |
| 2008 Q4 | 4.91 Million USD | -10.66% |
| 2008 Q2 | 6.45 Million USD | 9.46% |
| 2008 Q1 | 5.9 Million USD | 9.12% |
| 2008 Q3 | 5.49 Million USD | -14.85% |
| 2007 Q2 | 6.12 Million USD | 82.57% |
| 2007 Q1 | 3.35 Million USD | 12.84% |
| 2007 FY | 6.12 Million USD | 92.92% |
| 2007 Q4 | 5.4 Million USD | 1.62% |
| 2007 Q3 | 5.32 Million USD | -13.15% |
| 2006 FY | 3.17 Million USD | -15.35% |
| 2006 Q1 | 3.05 Million USD | 1.9% |
| 2006 Q4 | 2.97 Million USD | 0.81% |
| 2006 Q2 | 3.17 Million USD | 3.86% |
| 2006 Q3 | 2.95 Million USD | -7.12% |
| 2005 Q2 | 3.75 Million USD | 15.48% |
| 2005 FY | 3.75 Million USD | -27.79% |
| 2005 Q3 | 3.17 Million USD | -15.51% |
| 2005 Q1 | 3.24 Million USD | -14.32% |
| 2005 Q4 | 3 Million USD | -5.33% |
| 2004 Q2 | 5.19 Million USD | -26.41% |
| 2004 Q1 | 7.06 Million USD | -8.57% |
| 2004 Q4 | 3.79 Million USD | -15.38% |
| 2004 Q3 | 4.48 Million USD | -13.76% |
| 2004 FY | 5.19 Million USD | -34.84% |
| 2003 FY | 7.97 Million USD | -74.76% |
| 2003 Q1 | 8.03 Million USD | -11.06% |
| 2003 Q2 | 7.97 Million USD | -0.78% |
| 2003 Q3 | 7.73 Million USD | -2.95% |
| 2003 Q4 | 7.72 Million USD | -0.21% |
| 2002 Q2 | 31.58 Million USD | 35.53% |
| 2002 Q3 | 11.35 Million USD | -64.06% |
| 2002 Q4 | 9.03 Million USD | -20.4% |
| 2002 FY | 31.58 Million USD | 7.65% |
| 2002 Q1 | 23.3 Million USD | -5.29% |
| 2001 FY | 29.34 Million USD | 23.51% |
| 2001 Q4 | 24.61 Million USD | -19.32% |
| 2001 Q2 | 29.34 Million USD | -0.21% |
| 2001 Q3 | 30.5 Million USD | 3.95% |
| 2001 Q1 | 29.4 Million USD | -9.6% |
| 2000 Q3 | 25.72 Million USD | 8.28% |
| 2000 Q2 | 23.75 Million USD | -0.46% |
| 2000 Q1 | 23.86 Million USD | -22.0% |
| 2000 Q4 | 32.52 Million USD | 26.44% |
| 2000 FY | 23.75 Million USD | -38.93% |
| 1999 FY | 38.9 Million USD | -21.57% |
| 1999 Q4 | 30.6 Million USD | -5.26% |
| 1999 Q3 | 32.3 Million USD | -16.97% |
| 1999 Q2 | 38.9 Million USD | -9.53% |
| 1999 Q1 | 43 Million USD | 0.0% |
| 1998 Q2 | 49.6 Million USD | 9.49% |
| 1998 Q3 | 49.5 Million USD | -0.2% |
| 1998 Q4 | 43 Million USD | -13.13% |
| 1998 FY | 49.6 Million USD | 9.49% |
| 1998 Q1 | 45.3 Million USD | 1.12% |
| 1997 Q3 | 41.7 Million USD | -7.95% |
| 1997 FY | 45.3 Million USD | -18.08% |
| 1997 Q1 | 40.1 Million USD | -11.48% |
| 1997 Q2 | 45.3 Million USD | 12.97% |
| 1997 Q4 | 44.8 Million USD | 7.43% |
| 1996 Q4 | 45.3 Million USD | 0.0% |
| 1996 Q1 | 54.6 Million USD | 160.0% |
| 1996 FY | 55.3 Million USD | 219.65% |
| 1996 Q2 | 55.3 Million USD | 1.28% |
| 1996 Q3 | 45.3 Million USD | -18.08% |
| 1995 FY | 17.3 Million USD | 51.75% |
| 1995 Q1 | 15.9 Million USD | 22.31% |
| 1995 Q2 | 17.3 Million USD | 8.81% |
| 1995 Q3 | 15.7 Million USD | -9.25% |
| 1995 Q4 | 21 Million USD | 33.76% |
| 1994 Q1 | 11 Million USD | 3.77% |
| 1994 FY | 11.4 Million USD | 90.0% |
| 1994 Q2 | 11.4 Million USD | 3.64% |
| 1994 Q3 | 13.1 Million USD | 14.91% |
| 1994 Q4 | 13 Million USD | -0.76% |
| 1993 Q1 | 2.5 Million USD | 19.05% |
| 1993 Q2 | 6 Million USD | 140.0% |
| 1993 Q3 | 11.3 Million USD | 88.33% |
| 1993 Q4 | 10.6 Million USD | -6.19% |
| 1993 FY | 6 Million USD | 76.47% |
| 1992 Q1 | 3.9 Million USD | -2.5% |
| 1992 Q3 | 2.9 Million USD | -14.71% |
| 1992 FY | 3.4 Million USD | -17.07% |
| 1992 Q2 | 3.4 Million USD | -12.82% |
| 1992 Q4 | 2.1 Million USD | -27.59% |
| 1991 FY | 4.1 Million USD | 5.13% |
| 1991 Q2 | 4.1 Million USD | -12.77% |
| 1991 Q3 | 3.2 Million USD | -21.95% |
| 1991 Q4 | 4 Million USD | 25.0% |
| 1991 Q1 | 4.7 Million USD | 0.0% |
| 1990 Q2 | 3.9 Million USD | 0.0% |
| 1990 FY | 3.9 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BioElectronics Corporation | 16.62 Million USD | 99.284% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | 82.438% |
| Polarean Imaging plc | 2.58 Million USD | 95.389% |
| Avitar, Inc. | 11.59 Million USD | 98.974% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | 81.23% |
| AVITA Medical, Inc. | 19.86 Million USD | 99.401% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 94.381% |
| Össur hf. | 688.8 Million USD | 99.983% |
| Zecotek Photonics Inc. | 5.86 Million USD | 97.972% |
| QHSLab, Inc. | 2.05 Million USD | 94.215% |
| Wellstar International, Inc. | 55.99 Million USD | 99.787% |
| Össur hf. | 688.8 Million USD | 99.983% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 99.26% |
| Escalon Medical Corp. | 2.94 Million USD | 95.964% |
| Aurora Spine Corporation | 6.65 Million USD | 98.211% |
| BrainsWay Ltd. | 15.31 Million USD | 99.223% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 98.021% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 99.74% |
| Vivos Inc. | 245 Thousand USD | 51.429% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.995% |
| Kelyniam Global, Inc. | 1.01 Million USD | 88.252% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | 56.824% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 95.142% |
| Nanomix Corporation | 14.81 Million USD | 99.197% |
| Theraclion SA | 13.01 Million EUR | 99.086% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 97.678% |
| Positron Corporation | 2.02 Million USD | 94.126% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 96.714% |
| Lombard Medical, Inc. | 53.79 Million USD | 99.779% |
| ALR Technologies Inc. | 24.5 Million USD | 99.514% |
| Stratec SE | 271.97 Million USD | 99.956% |
| Vycor Medical, Inc. | 4.31 Million USD | 97.244% |
| Heart Tronics, Inc. | 1.09 Million USD | 89.13% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 94.955% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 97.827% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 99.819% |
| VMS Rehab Systems, Inc. | 201.36 USD | -58998.133% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 97.826% |
| Ingen Technologies, Inc. | 5.7 Million USD | 97.916% |
| Odyssey Group International, Inc. | 6.61 Million USD | 98.2% |
| ECGI Holdings, Inc. | 11.94 Million USD | 99.003% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 91.012% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 91.772% |
| Urologix, Inc. | 12.64 Million USD | 99.059% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 97.795% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 98.597% |
| SS Innovations International, Inc. | 11.18 Million USD | 98.936% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | 77.35% |
| Smith & Nephew plc | 4.76 Billion USD | 99.998% |
| NIOX Group Plc | 9.8 Million USD | 98.786% |
| Fuse Medical, Inc. | 15.11 Million USD | 99.212% |
| Broncus Holding Corporation | 10.43 Million USD | 98.859% |
| Brain Scientific Inc. | 7.42 Million USD | 98.398% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 99.648% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | 85.014% |